Hjem › Bløtvevssarkom › Ohio
Kliniske studier for Bløtvevssarkom i Ohio
23 studier for Bløtvevssarkom søker deltakere på steder i Ohio.
Byer i Ohio
Offisiell studietekst (engelsk)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Summa Health System - Akron Campus, Akron
- Cleveland Clinic Akron General, Akron
- Summa Health System - Barberton Campus, Barberton
- og 44 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Cleveland Clinic - Oncology Department, Cleveland
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06760819Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
- Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06528769DESTINY-PANTUMOUR04
- Research Site, Canton
- Research Site, Maumee
RekruttererObservasjonsstudie
Alder 18 til 130 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07124000Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1
Alder 12 til 85 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT03715933Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Nationwide Children's Hospital, Columbus
RekruttererFase 1/2
Alder 12 til 40 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07725380Actinium Therapy for Late-stage Aggressive Sarcomas
- Case Western, Cleveland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT07156565A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
- The James Cancer Hospital and Solove Research Institute, Columbus
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT06263231Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT05210374NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1/2
Opp til 30 år · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06239272Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
- OSU James Hospital, Columbus
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jul. 2026 · NCT07377747Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Ohio State University, Columbus
RekruttererFase 1/2
Alder 18 til 90 · Alle kjønn · Oppdatert 6. jul. 2026 · NCT06710756Integrated Cancer Repository for Cancer Research
- Aultman Alliance Community Hospital, Alliance
- Aultman Hospital, Canton
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- The Ohio State University Wexner Medical Center, Columbus
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 27. mai 2026 · NCT03093116An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
- Ohio State University, Columbus
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 11. feb. 2026 · NCT02677961Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekruttererFase 1/2
Alder 2 til 30 · Alle kjønn · Oppdatert 3. feb. 2026 · NCT0573406668Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
- Ohio State University Comprehensive Cancer Center, Columbus
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. feb. 2026 · NCT06500065cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Cleveland Clinic, Cleveland
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 11. des. 2025 · NCT06943521A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
RekruttererFase 2
18 Months – 40 Years · Alle kjønn · Oppdatert 12. aug. 2025 · NCT0513597564Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1/2
Alder 15 og eldre · Alle kjønn · Oppdatert 12. aug. 2025 · NCT06298916A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Cleveland Clinic, Cleveland
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. nov. 2024 · NCT05824975REtroperitoneal SArcoma Registry: an International Prospective Initiative
- The Ohio State University, Columbus
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 12. feb. 2019 · NCT03838718Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.